Ideal ARB for Hypertensive Diabetic Patients

Guideline-Based Approach to ARB Selection

• The American Diabetes Association recommends that ARBs should be titrated to the maximum tolerated dose indicated for blood pressure treatment, not just to blood pressure targets alone 1, 2, 3
• The American College of Cardiology and other guidelines suggest that any ARB at maximum tolerated dose is appropriate for hypertensive diabetic patients, as guidelines do not recommend one specific ARB over another 1, 2, 3
• ARBs are strongly recommended as first-line therapy in patients with albuminuria ≥300 mg/g creatinine (Grade A recommendation) 1, 2, 3
• ARBs are recommended as first-line therapy in patients with albuminuria 30-299 mg/g creatinine (Grade B recommendation) 1, 2, 3
• Patients with established coronary artery disease should be treated with ARBs 2
• Patients intolerant to ACE inhibitors should be treated with ARBs 1, 3

Dosing Strategy

• All ARBs should be titrated to the highest approved dose that the patient tolerates before adding additional antihypertensive agents 1, 2, 4

Blood Pressure Targets and Combination Therapy

• Target blood pressure is <130/80 mmHg for most diabetic patients 2, 3
• When blood pressure is ≥150/90 mmHg, initiate ARB plus a second agent (thiazide-like diuretic or dihydropyridine calcium channel blocker) immediately 2
• Multiple-drug therapy is typically required to achieve blood pressure targets in diabetic patients 1, 2, 3

Critical Contraindications

• Never combine ARBs with ACE inhibitors (Grade A recommendation) 1, 2, 3
• Never combine ARBs with direct renin inhibitors 1, 2, 3
• Never combine ARBs with another ARB 6

Monitoring Requirements

• Monitor serum creatinine/eGFR, serum potassium, and blood pressure within 2-4 weeks of initiation or dose increase 2, 3, 4, 5
• Continue ARB therapy unless serum creatinine rises >30% within 4 weeks, uncontrolled hyperkalemia despite medical management, or symptomatic hypotension 3, 4

Special Populations

• Women of childbearing potential: ARBs are contraindicated in pregnancy and should be discontinued in women considering pregnancy or who become pregnant 2, 4

Resistant Hypertension

• If blood pressure remains uncontrolled on three agents (including ARB, diuretic, and calcium channel blocker), consider adding a mineralocorticoid receptor antagonist (Grade B recommendation) 1, 3